Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Recurso digital |
| Langue: | |
| Publié: |
Zenodo
2025
|
| Accès en ligne: | https://doi.org/10.5281/zenodo.14619275 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Table des matières:
- <p>Background: High risk factors during pregnancy adversely affect the maternal and<br>foetal outcome increasing perinatal morbidity and mortality. Antepartum foetal<br>surveillance can detect foetal hypoxia and acidemia before it becomes irreversible.<br>Non- stress test (NST) is simple and cost-effective method of antepartum foetal<br>surveillance. The objective of the study was to analyse the predictive value of NST in<br>evaluating perinatal outcome in high-risk pregnancies.<br>Materials and Method: Present study was carried out on 100 high-risk pregnant<br>women with singleton pregnancy, of more than 34 weeks period of gestation.All<br>participants underwent prenatal non-stress testing (NST). Based on the results, the<br>cases were categorized into two groups: reactive NST and non-reactive NST. Perinatal<br>outcomes were then assessed and compared between the two groups.<br>Results: The common risk factorsobserved in our study were gestational hypertension<br>(19%), anaemia (17%), hypothyroidism (14%), pre-eclampsia (10%), oligohydramnios<br>(10%).Around 66% of the participants had reactive prenatal NST while 34% cases had<br>non-reactive NST. Around 41% of the infants were low birth weight in non-reactive<br>NST group while 13.6% in reactive group. Total 20.59% babies in non-reactive NST<br>group had low Apgar at 5 minutes requiring NICU admission while 6.06% babies in<br>reactive NST group had low Apgar requiring admission.<br>Conclusion: Present study reveals significant difference in perinatal outcomes in highrisk</p> <p>cases with reactive and non-reactive NST. NST can be used for identifying the<br>foetuses at risk of asphyxia and avoiding unnecessary delay in intervention. It can be<br>used as single best screening in low resource centres to screen high risk antenatal cases.</p>